Skip to main content
Clinical Trials/EUCTR2021-006860-26-NL
EUCTR2021-006860-26-NL
Active, not recruiting
Phase 1

Pharmacokinetic and pharmacodynamic target attainment of cefuroxime in adult patients on general wards with different degrees of renal function: a prospective observational cohort study - Target Attainment Cefuroxime

oordwest Ziekenhuisgroep0 sites45 target enrollmentJanuary 5, 2022

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Bacterial infections
Sponsor
oordwest Ziekenhuisgroep
Enrollment
45
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 5, 2022
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
oordwest Ziekenhuisgroep

Eligibility Criteria

Inclusion Criteria

  • Receiving cefuroxime therapy intravenous (iv) as part of standard care
  • Age \= 18 years
  • Admitted to a general ward of Noordwest Ziekenhuisgroep – location Alkmaar
  • Informed consent is obtained
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 45
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 45

Exclusion Criteria

  • Mentally incapacitated patients, i.e. a minor or legally incompetent adult
  • Renal replacement therapy during treatment with cefuroxime
  • Patients admitted to the intensive care unit (ICU)
  • Severely burned patients, defined as a burned surface \= 10%
  • Patients with cystic fibrosis
  • Informed consent is not obtained

Outcomes

Primary Outcomes

Not specified

Similar Trials